Janus Henderson Group’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
2022
Q2
$524K Hold
2022
Q1
$523K Hold
2021
Q4
$516K Buy
2021
Q3
$464K Hold
2021
Q2
$467K Buy
2021
Q1
$198K Buy